Levine, Louise R.

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

Krystal, J. H., Abi-Saab, W., Perry, E., D’Souza, D. C., Liu, N., Gueorguieva, R., McDougall, L., Hunsberger, T., Belger, A., Levine, L., et al. (2005) · Psychopharmacology

Neuroscience and Neuropharmacology ResearchTreatment of Major Depression

Cited by 272

The cost of treating anxiety: the medical and demographic correlates that impact total medical costs

Marciniak, M. D., Lage, M. J., Dunayevich, E., Russell, J. M., Bowman, L., Landbloom, R. P., & Levine, L. R. (2005) · Depression and Anxiety

Mental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 204

Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders

Wilens, T. E., Adler, L. A., Weiss, M. D., Michelson, D., Ramsey, J. L., Moore, R. J., Renard, D., Brady, K. T., Trzepacz, P. T., Schuh, L. M., et al. (2008) · Drug and Alcohol Dependence

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 171

Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder

Wilens, T. E., Newcorn, J. H., Kratochvil, C. J., Gao, H., Thomason, C. K., Rogers, A. K., Feldman, P. D., & Levine, L. R. (2006) · The Journal of Pediatrics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 102

Functional Outcomes in the Treatment of Adults With ADHD

Adler, L. A., Spencer, T. J., Levine, L. R., Ramsey, J. L., Tamura, R., Kelsey, D., Ball, S. G., Allen, A. J., & Biederman, J. (2008) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 93

Atomoxetine versus Methylphenidate in Paediatric Outpatients with Attention Deficit Hyperactivity Disorder: A Randomized, Double-Blind Comparison Trial

Wang, Y., Zheng, Y., Du, Y., Song, D. H., Shin, Y.-J., Cho, S. C., Kim, B. N., Ahn, D. H., Marquez-Caraveo, M. E., Gao, H., et al. (2007) · Australian & New Zealand Journal of Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 84

Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder

Bangs, M. E., Hazell, P., Danckaerts, M., Hoare, P., Coghill, D. R., Wehmeier, P. M., Williams, D. W., Moore, R. J., Levine, L., & for the Atomoxetine ADHD/ODD Study Group (2008) · Pediatrics

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 79